Literature DB >> 8023789

Antistreptokinase antibodies before and after streptokinase therapy in patients with acute myocardial infarction from areas endemic for streptococcal infection and influence on reperfusion rates.

G Shaila1, Y S Chandrashekhar, N Kumar, N K Ganguly, I S Anand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8023789     DOI： 10.1016/0002-9149(94)90099-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  6 in total

1.  Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection.

Authors:  N Blackwell; A Hollins; G Gilmore; R Norton
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

2.  A rapid agglutination assay to detect anti-streptokinase antibodies.

Authors:  J P McRedmond; N T Mulvihill; M Kane; B Burke; B Aloul; T Forde; M Walsh; D J Fitzgerald
Journal:  Ir J Med Sci       Date:  2004 Oct-Dec       Impact factor: 1.568

3.  Antistreptokinase antibodies and the response to thrombolysis with streptokinase in patients with acute ST elevation myocardial infarction.

Authors:  M S K Subhendu; Oommen K George; John A Jude Prakash
Journal:  Heart Asia       Date:  2012-01-01

Review 4.  Criteria for drug usage review of thrombolytics in acute myocardial infarction.

Authors:  S McGlynn
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

Review 5.  Does the potential for development of streptokinase antibodies change the risk-benefit ratio in older patients?

Authors:  J Brügemann; P A de Graeff; J van der Meer; K I Lie
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

Review 6.  How safe is the readministration of streptokinase?

Authors:  H S Lee
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.